about
Inhibition of activator protein-1, NF-kappa B, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acidMetallic nickel nanoparticles may exhibit higher carcinogenic potential than fine particles in JB6 cellsSignal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancerPersistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animalsIdentification of a human NF-kappaB-activating protein, TAB3Direct inhibition of the NOTCH transcription factor complexSuppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamideSTAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin geneIdentification of the 'NORE' (N-Oct-3 responsive element), a novel structural motif and composite element.Sequence- and structural-selective nucleic acid binding revealed by the melting of mixtures.A Central Role for STAT3 in Gammaherpesvirus-Life Cycle and -DiseasesSignal transducer and activator of transcription 3 regulation by novel binding partnersMay the Best Molecule Win: Competition ESI Mass SpectrometryContact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug deliverySTAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapySTAT3 inhibitors for cancer therapy: Have all roads been explored?Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactionsDNA mimicry by a high-affinity anti-NF- B RNA aptamerRegulating the ARNT/TACC3 Axis: Multiple Approaches to Manipulating Protein/Protein Interactions with Small MoleculesStructure-function analyses of the human SIX1–EYA2 complex reveal insights into metastasis and BOR syndromeBET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor ModelsAcetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase InhibitorsTargeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentMolecular regulation of human cathepsin B: implication in pathologiesBET bromodomain inhibition as a therapeutic strategy to target c-MycProline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivoDangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancerPulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanismsThe Mediator complex and transcription regulationNuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progressionNecdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancerModulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancerNuclear termination of STAT3 signaling through SIPAR (STAT3-Interacting Protein As a Repressor)-dependent recruitment of T cell tyrosine phosphatase TC-PTPAstaxanthin inhibits JAK/STAT-3 signaling to abrogate cell proliferation, invasion and angiogenesis in a hamster model of oral cancerRegistered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemiaRegistered report: BET bromodomain inhibition as a therapeutic strategy to target c-MycTargeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines
P2860
Q23920074-7BBB0632-632E-46FF-BAA5-D58E84F1203EQ23920638-F4B58816-A29C-4814-AC91-898B1E5C8FCBQ24300274-F38BAD1A-7ECD-427F-B02E-9ACB3DADFFBFQ24302687-BE877470-469C-4B6A-89DD-A32CC7C0A910Q24312920-BA7A3C1D-F8B2-4C80-AC7E-3580E11206F8Q24563431-FC114825-6676-4A20-A091-5EBBE94CEC98Q24621651-832C2442-1851-45ED-BE59-AAFC8C91B2C0Q24634015-DE2DB290-C4E8-47F9-97CB-0493CC694083Q24669875-E225BA63-9859-44F2-8980-FE55536A58DFQ24684667-388F0926-6271-48EF-8BE8-0ADB097BCE59Q24802996-F78F735B-FE99-45D0-93B1-E30D1610A5A5Q25257441-33DCCBE2-9C63-4371-983F-16AC4EAF1604Q26741576-4CA7CFDC-3205-43B0-A309-947B5D43591BQ26775416-FF4E09D9-2A41-4DA4-AF5C-69436E5D6910Q26779012-C2E21E72-F3EE-4295-BFC5-0AE7AE4B8631Q26795703-2E39AD6F-6377-4BCA-9F73-D980B8F7E459Q27003190-3AD20779-AC60-495B-AE8F-D4481C5753D5Q27021266-DA70F6C6-DCEF-4085-B3F2-D2731A394613Q27642107-F6CA654D-9DFD-4493-9C00-3E442562F32CQ27649437-0A46507E-3E68-4796-BDD0-8EE717A315F4Q27675499-8326A628-A6E7-436A-9737-C7FD7FA5200BQ27676610-2457745C-1361-4EBB-AC86-872F8EDCDCD2Q27679878-BE7C85A9-D0DA-4358-8021-F705A1BFB3CCQ27681896-F7BA4025-FA5D-4499-8A0E-870FFFAE423FQ28076462-154AEFA2-8206-406F-A364-9B5FBB37CC96Q28190363-AA3B301D-89BC-4904-B4A7-9C3CBD676501Q28247024-9390ADEE-7175-4CC1-B824-853C580EA622Q28259770-1DFF777E-0AAD-43D6-B54C-7C6944A07668Q28263669-9C98C04D-A63C-40DD-8597-1EECC62F5D53Q28267996-B2F7D35E-7BBB-4CCF-8047-5A5993037F69Q28297490-70AABF79-0715-4C0B-BEED-85D30164C413Q28299679-B22078E9-E6B5-4652-A53F-9B7BA2199205Q28389404-80167F9C-85E9-42B7-9856-48DDDFAD4E46Q28477663-CC323814-F4C5-43C3-9F88-9A04548006A7Q28482457-FB81370C-298D-4B6A-8E92-79CE6771C007Q28510611-68ED0693-33CF-4F26-A23D-22E5162808AFQ28543608-DE186F7D-7ABC-49A6-B99D-CA3FBC31FDD0Q28608331-35C2773A-88FD-4A97-916C-66C051BB62E3Q28647939-2EC52B15-8232-463C-8239-F3558E9C673DQ28771722-66FBDAE6-E3DC-449F-9E96-AC7A0F8C1019
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Transcription factors as targets for cancer therapy.
@ast
Transcription factors as targets for cancer therapy.
@en
Transcription factors as targets for cancer therapy.
@nl
type
label
Transcription factors as targets for cancer therapy.
@ast
Transcription factors as targets for cancer therapy.
@en
Transcription factors as targets for cancer therapy.
@nl
prefLabel
Transcription factors as targets for cancer therapy.
@ast
Transcription factors as targets for cancer therapy.
@en
Transcription factors as targets for cancer therapy.
@nl
P356
P1476
Transcription factors as targets for cancer therapy.
@en
P2093
James E Darnell
P2888
P304
P356
10.1038/NRC906
P407
P577
2002-10-01T00:00:00Z
P5875
P6179
1046543214